School of Medicine
Showing 81-100 of 128 Results
-
Ramsudha Narala
Clinical Assistant Professor, Ophthalmology
BioDr. Ramsudha Narala is a board certified ophthalmologist who specializes in vitreoretinal surgery and ocular oncology. Dr. Narala grew up in Fresno, California and following high school, she attended the 8 year combined undergraduate-medical school program at Saint Louis University in Saint Louis, Missouri.
After medical school, she completed her ophthalmology residency at Kresge Eye Institute in Detroit, MI, where she received the best resident teacher award and highest resident ophthalmic knowledge assessment program exam score award. She then joined the University of Southern California in Los Angeles, California for a 2 year vitreoretinal surgery fellowship where she was elected chief vitreoretinal surgery fellow. Following completion of vitreoretinal surgery fellowship, she pursued an advanced training fellowship in ocular oncology at Byers Eye Institute at Stanford University.
Dr. Narala has authored many peer-reviewed scientific publications and textbook chapters on vitreoretinal diseases and ocular oncology. She is also dedicated to education and teaching medical students, residents, and fellows.
Dr. Narala's clinical practice is mainly based at Santa Clara Valley Medical Center. -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Chi Mong Christopher Or
Clinical Assistant Professor, Ophthalmology
BioDr. Or is a board-certified ophthalmologist and family medicine physician. He received advanced uveitis training through the uveitis and medical retina fellowship at Stanford University School of Medicine. Prior to residency, he also completed a fellowship in optical coherence tomography (OCT) research at the New England Eye Center. Dr. Or treats patients at the Byers Eye Institute at Stanford Health Care and Menlo Medical Clinic in Menlo Park. He is also a clinical assistant professor in the Department of Ophthalmology at the Stanford University School of Medicine.
Dr. Or treats many eye diseases, including age-related macular degeneration, cataracts, and uveitis. He emphasizes using imaging to diagnose and monitor the progression of eye conditions.
His research interests include eye imaging methods such as OCT and OCT angiography (OCTA). Dr. Or has studied these imaging techniques for years, first as a research assistant, then as a fellow, and now as a principal investigator. He has studied using these imaging techniques for diagnosing and monitoring age-related macular degeneration, diabetic retinopathy, and uveitis.
He is actively involved in clinical trials for optical imaging and serves as principal investigator in clinical trials assessing different medications to treat eye diseases.
Dr. Or has published numerous peer-reviewed articles on topics such as optical imaging, autoimmune eye diseases, and vascular eye diseases. His research has appeared in prestigious journals including Clinical Ophthalmology, Ocular Immunology and Inflammation, Retina, the American Journal of Ophthalmology, and many other ophthalmology journals worldwide.
He is a member of the American Academy of Ophthalmology, the American Society of Retina Specialists, and the Association for Research in Vision and Ophthalmology (ARVO). Dr. Or has presented his research at various national and international meeting several times. -
Daniel Palanker, PhD
Professor of Ophthalmology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsInteractions of electric field and light with biological cells and tissues and their applications to imaging, diagnostics, therapeutics and prosthetics, primarily in ophthalmology.
Specific fields of interest:
Electronic retinal prosthesis;
Electronic enhancement of tear secretion;
Electronic control of blood vessels;
Non-damaging retinal laser therapy;
Ultrafast laser surgery;
Interferometric imaging of neural signals;
Cell transplantation and retinal plasticity. -
Carolyn K. Pan, MD
Clinical Associate Professor, Ophthalmology
BioDr. Pan is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon. She focuses on retinal vascular diseases, macular degeneration, and surgical repair of retinal detachments, macular pathology, and complications from cataract surgery. She has co-authored peer-reviewed articles on topics ranging from optical coherence tomography imaging to embryonic stem cells for macular degeneration.
In addition to her clinical practice, she is dedicated to the education and training of medical students, residents, and fellows. As recognition of her efforts, she received the Faculty Teaching Award in 2016 from the Byers Eye Institute at Stanford University, was the Associate Residency Program Director from 2020 to 2023, and currently serves as the Residency Program Director. Her educational efforts also extend beyond the department - since 2016, she has served on the annual meeting planning committee for the American Academy of Ophthalmology and is currently Associate Secretary of the Annual Meeting and Chair of the Special Projects Committee.
Dr. Pan's clinical practice is mainly based at Santa Clara Valley Medical Center, Stanford's affiliate county hospital, where she is chief of the retina service. -
Suzann Pershing, MD
Associate Professor of Ophthalmology
BioDr. Pershing is on the ophthalmology faculty at Stanford University School of Medicine, with an academic career blending clinical practice, teaching, research, and administration. She serves as Chief of Ophthalmology and Eye Care Services for the VA Palo Alto Health Care System and as Vice Chair for Education in the Stanford Department of Ophthalmology, after five years as Program Director for the ophthalmology residency.
As an educator she seeks to bring a "precision" approach to graduate medical education, incorporating innovation and research rigor. She is committed to program diversity and inclusion and excited to innovate and implement novel approaches to ophthalmology education. Specific areas of interest include competency-based education, career pathways and career development, and leadership development, with programmatic initiatives such as Stanford Ophthalmology's 4-year research track residency program (SOAR), opportunities for resident elective scholarly activity, and efforts to develop a valuable internship program for incoming ophthalmology residents at Stanford. Dr. Pershing's active research includes efforts to enhance diversity in residency selection, using AI semi-supervised models to augment the application review process, and predictive modeling to optimize cataract surgery case selection and scheduling.
Her broader research interests focus on utilization of big data, biomedical informatics techniques, and evidence-based medicine to study clinical associations and outcomes, health care utilization, disease progression, and cost-effectiveness of ophthalmic treatment, as well as a special interest in the relationship between visual impairment and cognitive impairment. Dr. Pershing is active in big data initiatives and analysis, including collaborative projects at Stanford and serving as site PI for the American Academy of Ophthalmology (AAO) IRIS Registry analytic group at Stanford. She also serves on the American Board of Medical Specialties Database and Information Technology Advisory Committee (DITAC), the AAO Medical Information Technology Committee, and AAO Committee on Aging. Through this and her other work, she is engaged in efforts to use diverse data sources to facilitate improved quality of care, continuing certification, and practice and outcomes assessments. Dr. Pershing is also involved in health policy, including helping to develop CMS episode-based cost measures for MIPS, and she is interested in health care innovation—technology, quality, and delivery systems.
Dr. Pershing also serves as faculty advisor for the Alpha Omega Alpha medical honor society Stanford association, with focus on resident initiatives, and mentors both medical students and undergraduate students. -
Ehsan Rahimy
Adjunct Clinical Assistant Professor, Ophthalmology
BioDr. Ehsan Rahimy specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is passionate about the interplay between technology and medicine, and how ongoing advancements will transform healthcare delivery in the near future. Dr. Rahimy is frequently consulted for collaborative research endeavors and advises on numerous early stage companies involved in ophthalmology, telemedicine, A.I., and other medtech innovation.
Dr. Rahimy graduated with highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of a select few junior inductees into the Alpha Omega Alpha (AOA) Honor Society. He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award. Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field's leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award. -
Tawna L. Roberts, OD, PhD
Associate Professor of Ophthalmology (Pediatric) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsOur research efforts are funded by grants from the National Eye Institute, Department of Defense, and various foundations to study vision development in infants and young children as well as binocular vision disorders in adolescents and adults with concussions. Our focus is to identify underlying mechanisms that will inform clinical treatment approaches and ultimately leading to the prevention of strabismus, amblyopia, and binocular vision disorders.
-
Jennifer Rose-Nussbaumer
Associate Professor of Ophthalmology
BioJennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on corneal transplant, complex cataract surgery and treatment of infectious keratitis. After completing her fellowship in Cornea and External Disease at the University of California, San Francisco, she stayed on faculty and remained there until she transitioned to Stanford in 2021. She continues to collaborate closely with the FI Proctor Foundation as an Associate Proctor Researcher.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded researcher who focuses on randomized clinical trials in ophthalmology. She is the PI on a UG1 grant, Descemet Endothelial Thickness Comparison Trial (DETECT), a randomized clinical trial comparing UT-DSAEK to DMEK and ripasudil versus placebo in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also the PI on a UG1 grant, the Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II), a randomized clinical trial in collaboration with Aravind Eye hospital in India and the University of Sao Paulo looking at the benefit of adjunctive topical steroids, corneal crosslinking or rose bengal photodynamic therapy in the treatment of infectious ulcers.
As a native of Northern California, she loves spending time with her family and Bernese Mountain Dog, Kenji, exploring California's natural beauty through hiking and camping. -
Daniel Rubin
Professor of Biomedical Data Science, of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology
Current Research and Scholarly InterestsMy research interest is imaging informatics--ways computers can work with images to leverage their rich information content and to help physicians use images to guide personalized care. Work in our lab thus lies at the intersection of biomedical informatics and imaging science.
-
Steven Sanislo, MD
Clinical Professor, Ophthalmology
BioDr Sanislo has over 20 years of experience in clinical and surgical practice in retinal and vitreoretinal diseases. He is the senior vitreoretinal surgeon at Stanford and maintains a large clinical practice as well as teaching ophthalmology residents and retina fellows. He also participates in clincal reasearch for varying retinal conditions. Dr. Sanislo recieved ophthalmology training as a resident here at Stanford, and recieved vitreoretinal training as a fellow at the Cleveland Clinic Foundation.
Research interests include treatment of age-related macular degeneration, diabetic retinopathy and other retinal diseases.
Dr. Sanislo has extensive clinical and surgical experience in the following diseases:
- Age-related macular degeneration
- Posterior uveitis / infectious and inflammatory disease of the posterior segment
- Diabetic retinopathy
- Myopic degeneration / pathologic myopia
- Macular pucker / epiretinal membranes
- Macular hole
- Repair of simple and complex retinal detachments
- Macular edema
- Retinal vascular occlusion -
Yasir Sepah
Assistant Professor (Research) of Ophthalmology
Current Research and Scholarly InterestsYasir's primary focus is on early identification of ocular diseases and objective assessment of response to therapy via biomarker (imaging and molecular) discovery and endpoints development for clinical trials. His lab is also developing and implementing protocols and methods to make decentralized clinical trials in ophthalmology viable.
Yasir is also engaged in developing low-tech, low cost and less intelligent solutions in order to improve patient's access to care.
